Structure

Physi-Chem Properties

Molecular Weight:  612.17
Volume:  554.954
LogP:  -0.486
LogD:  -0.443
LogS:  -2.524
# Rotatable Bonds:  7
TPSA:  258.43
# H-Bond Aceptor:  16
# H-Bond Donor:  9
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.127
Synthetic Accessibility Score:  5.1
Fsp3:  0.519
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.542
MDCK Permeability:  3.710910095833242e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.88
20% Bioavailability (F20%):  0.008
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.137
Plasma Protein Binding (PPB):  66.67398071289062%
Volume Distribution (VD):  0.606
Pgp-substrate:  21.917245864868164%

ADMET: Metabolism

CYP1A2-inhibitor:  0.02
CYP1A2-substrate:  0.105
CYP2C19-inhibitor:  0.009
CYP2C19-substrate:  0.09
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.061
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.124
CYP3A4-inhibitor:  0.004
CYP3A4-substrate:  0.003

ADMET: Excretion

Clearance (CL):  1.135
Half-life (T1/2):  0.636

ADMET: Toxicity

hERG Blockers:  0.181
Human Hepatotoxicity (H-HT):  0.109
Drug-inuced Liver Injury (DILI):  0.948
AMES Toxicity:  0.553
Rat Oral Acute Toxicity:  0.014
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.244
Carcinogencity:  0.161
Eye Corrosion:  0.003
Eye Irritation:  0.034
Respiratory Toxicity:  0.013

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470448

Natural Product ID:  NPC470448
Common Name*:   7,9,10-Trihydroxy-5-Methoxy-3-Methyl-1H-Naphtho[2,3-C]Pyran-1-One-9-O-Beta-D-Glucopyranosyl-(1->6)-Beta-D-Glucopyranoside
IUPAC Name:   7,10-dihydroxy-5-methoxy-3-methyl-9-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxybenzo[g]isochromen-1-one
Synonyms:  
Standard InCHIKey:  LTXGXYWAIVIDEM-QEKRRRGYSA-N
Standard InCHI:  InChI=1S/C27H32O16/c1-8-3-10-16(25(37)40-8)19(32)15-11(24(10)38-2)4-9(29)5-12(15)41-27-23(36)21(34)18(31)14(43-27)7-39-26-22(35)20(33)17(30)13(6-28)42-26/h3-5,13-14,17-18,20-23,26-36H,6-7H2,1-2H3/t13-,14-,17-,18-,20+,21+,22-,23-,26-,27-/m1/s1
SMILES:  OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)cc4c3c(O)c3c(c4OC)cc(oc3=O)C)[C@@H]([C@H]([C@@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2037051
PubChem CID:   57409959
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001640] Naphthopyrans
        • [CHEMONTID:0001641] Naphthopyranones
          • [CHEMONTID:0001646] Naphthopyranone glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33486 paepalanthus geniculatus Species Eriocaulaceae Eukaryota Flowers Santana do Riacho, State Minas Gerais, Brazil n.a. PMID[22506638]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 1.038 mM PMID[490434]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470448 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470453
1.0 High Similarity NPC470452
1.0 High Similarity NPC164047
0.994 High Similarity NPC84494
0.994 High Similarity NPC245059
0.9759 High Similarity NPC470454
0.9759 High Similarity NPC199533
0.9759 High Similarity NPC63105
0.9581 High Similarity NPC213052
0.9415 High Similarity NPC475161
0.9415 High Similarity NPC477860
0.9401 High Similarity NPC259905
0.9364 High Similarity NPC241847
0.9353 High Similarity NPC46958
0.9345 High Similarity NPC298778
0.9294 High Similarity NPC68381
0.9281 High Similarity NPC178851
0.9253 High Similarity NPC221140
0.9253 High Similarity NPC475352
0.9253 High Similarity NPC473686
0.9253 High Similarity NPC87583
0.9253 High Similarity NPC475220
0.9253 High Similarity NPC229817
0.924 High Similarity NPC475246
0.9231 High Similarity NPC210808
0.9231 High Similarity NPC199079
0.9226 High Similarity NPC249977
0.9181 High Similarity NPC3718
0.9181 High Similarity NPC474345
0.9176 High Similarity NPC9002
0.9176 High Similarity NPC271385
0.9176 High Similarity NPC288152
0.9176 High Similarity NPC30432
0.9176 High Similarity NPC257011
0.9176 High Similarity NPC76128
0.9176 High Similarity NPC137871
0.9176 High Similarity NPC111536
0.9176 High Similarity NPC5029
0.9162 High Similarity NPC17432
0.9153 High Similarity NPC48474
0.9138 High Similarity NPC293227
0.9138 High Similarity NPC473717
0.9138 High Similarity NPC475662
0.9138 High Similarity NPC473631
0.9133 High Similarity NPC299149
0.9133 High Similarity NPC277710
0.9133 High Similarity NPC153578
0.9133 High Similarity NPC114257
0.9107 High Similarity NPC99216
0.9107 High Similarity NPC7752
0.9106 High Similarity NPC470198
0.9106 High Similarity NPC282474
0.9106 High Similarity NPC470200
0.9106 High Similarity NPC470194
0.9106 High Similarity NPC470195
0.9106 High Similarity NPC316274
0.9106 High Similarity NPC470197
0.9106 High Similarity NPC470193
0.9106 High Similarity NPC470196
0.9059 High Similarity NPC473202
0.9053 High Similarity NPC70441
0.9048 High Similarity NPC124155
0.9048 High Similarity NPC257566
0.9045 High Similarity NPC264302
0.9045 High Similarity NPC321046
0.9017 High Similarity NPC102053
0.9017 High Similarity NPC475233
0.9012 High Similarity NPC472054
0.9012 High Similarity NPC25724
0.9006 High Similarity NPC241874
0.9006 High Similarity NPC477572
0.9006 High Similarity NPC477571
0.9006 High Similarity NPC477573
0.9 High Similarity NPC314687
0.8994 High Similarity NPC314459
0.8994 High Similarity NPC470199
0.8989 High Similarity NPC314672
0.8989 High Similarity NPC472721
0.8989 High Similarity NPC31208
0.8989 High Similarity NPC469652
0.8989 High Similarity NPC472724
0.8989 High Similarity NPC160543
0.8989 High Similarity NPC93065
0.8989 High Similarity NPC472720
0.8988 High Similarity NPC44947
0.8988 High Similarity NPC216752
0.8988 High Similarity NPC298171
0.8983 High Similarity NPC105591
0.8982 High Similarity NPC328093
0.8977 High Similarity NPC148710
0.8977 High Similarity NPC49690
0.8976 High Similarity NPC257309
0.896 High Similarity NPC102028
0.8956 High Similarity NPC131405
0.8956 High Similarity NPC174140
0.8953 High Similarity NPC472386
0.8947 High Similarity NPC222455
0.8947 High Similarity NPC246274
0.8933 High Similarity NPC223534
0.8933 High Similarity NPC158214
0.8933 High Similarity NPC240200
0.8933 High Similarity NPC290289
0.8929 High Similarity NPC101636
0.8929 High Similarity NPC47923
0.8927 High Similarity NPC111490
0.8927 High Similarity NPC261623
0.892 High Similarity NPC470446
0.892 High Similarity NPC470445
0.892 High Similarity NPC470449
0.892 High Similarity NPC470447
0.8914 High Similarity NPC58538
0.8914 High Similarity NPC212290
0.8908 High Similarity NPC255799
0.8908 High Similarity NPC312630
0.8908 High Similarity NPC324220
0.8902 High Similarity NPC203751
0.8902 High Similarity NPC98776
0.8902 High Similarity NPC208668
0.8902 High Similarity NPC85368
0.8902 High Similarity NPC204693
0.8895 High Similarity NPC78734
0.8895 High Similarity NPC52353
0.8895 High Similarity NPC313304
0.8895 High Similarity NPC76047
0.8895 High Similarity NPC150767
0.8895 High Similarity NPC218488
0.8883 High Similarity NPC187632
0.8876 High Similarity NPC260521
0.8876 High Similarity NPC469649
0.8876 High Similarity NPC190450
0.887 High Similarity NPC224557
0.887 High Similarity NPC470451
0.887 High Similarity NPC75574
0.887 High Similarity NPC470455
0.887 High Similarity NPC292706
0.8869 High Similarity NPC470358
0.8857 High Similarity NPC472387
0.8857 High Similarity NPC477683
0.8857 High Similarity NPC477682
0.8851 High Similarity NPC146803
0.8851 High Similarity NPC142996
0.8844 High Similarity NPC267254
0.8844 High Similarity NPC259152
0.8844 High Similarity NPC256760
0.8844 High Similarity NPC254540
0.8844 High Similarity NPC475155
0.8844 High Similarity NPC156977
0.8844 High Similarity NPC3583
0.8844 High Similarity NPC211594
0.8844 High Similarity NPC172807
0.8844 High Similarity NPC315619
0.8844 High Similarity NPC301683
0.884 High Similarity NPC477082
0.8837 High Similarity NPC472381
0.8837 High Similarity NPC5319
0.8837 High Similarity NPC472383
0.8833 High Similarity NPC471091
0.8833 High Similarity NPC478034
0.8833 High Similarity NPC97924
0.8833 High Similarity NPC40078
0.883 High Similarity NPC298666
0.883 High Similarity NPC178173
0.883 High Similarity NPC64425
0.883 High Similarity NPC68592
0.883 High Similarity NPC262222
0.8827 High Similarity NPC477083
0.8827 High Similarity NPC473618
0.8827 High Similarity NPC477081
0.882 High Similarity NPC469650
0.8817 High Similarity NPC303913
0.8814 High Similarity NPC313452
0.881 High Similarity NPC22062
0.881 High Similarity NPC473634
0.881 High Similarity NPC138811
0.8807 High Similarity NPC241423
0.8807 High Similarity NPC470444
0.8807 High Similarity NPC470443
0.8807 High Similarity NPC126784
0.8807 High Similarity NPC473682
0.8807 High Similarity NPC110941
0.8807 High Similarity NPC473571
0.8802 High Similarity NPC261866
0.88 High Similarity NPC470949
0.88 High Similarity NPC169733
0.88 High Similarity NPC314489
0.88 High Similarity NPC471669
0.88 High Similarity NPC289876
0.88 High Similarity NPC232818
0.88 High Similarity NPC472380
0.88 High Similarity NPC472382
0.88 High Similarity NPC472384
0.88 High Similarity NPC89127
0.88 High Similarity NPC297574
0.88 High Similarity NPC65563
0.88 High Similarity NPC198893
0.8793 High Similarity NPC263119
0.8793 High Similarity NPC239549
0.8793 High Similarity NPC166674
0.8793 High Similarity NPC51774
0.8793 High Similarity NPC473550

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470448 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8837 High Similarity NPD7804 Clinical (unspecified phase)
0.8786 High Similarity NPD7472 Approved
0.8771 High Similarity NPD7879 Clinical (unspecified phase)
0.8728 High Similarity NPD7054 Approved
0.8693 High Similarity NPD8312 Approved
0.8693 High Similarity NPD8313 Approved
0.8686 High Similarity NPD7251 Discontinued
0.8678 High Similarity NPD7074 Phase 3
0.8639 High Similarity NPD4381 Clinical (unspecified phase)
0.8636 High Similarity NPD7808 Phase 3
0.8636 High Similarity NPD4338 Clinical (unspecified phase)
0.8629 High Similarity NPD6797 Phase 2
0.8596 High Similarity NPD6959 Discontinued
0.858 High Similarity NPD6559 Discontinued
0.8514 High Similarity NPD5844 Phase 1
0.8482 Intermediate Similarity NPD7783 Phase 2
0.8482 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8474 Intermediate Similarity NPD8151 Discontinued
0.8353 Intermediate Similarity NPD7819 Suspended
0.8352 Intermediate Similarity NPD3818 Discontinued
0.8333 Intermediate Similarity NPD6232 Discontinued
0.8314 Intermediate Similarity NPD7075 Discontinued
0.8307 Intermediate Similarity NPD7435 Discontinued
0.8295 Intermediate Similarity NPD7473 Discontinued
0.8284 Intermediate Similarity NPD4380 Phase 2
0.8251 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8249 Intermediate Similarity NPD7228 Approved
0.815 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD6779 Approved
0.8148 Intermediate Similarity NPD6781 Approved
0.8148 Intermediate Similarity NPD6782 Approved
0.8148 Intermediate Similarity NPD6780 Approved
0.8148 Intermediate Similarity NPD6778 Approved
0.8148 Intermediate Similarity NPD6777 Approved
0.8148 Intermediate Similarity NPD6776 Approved
0.814 Intermediate Similarity NPD8455 Phase 2
0.814 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.814 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8136 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8136 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8136 Intermediate Similarity NPD6166 Phase 2
0.8115 Intermediate Similarity NPD7698 Approved
0.8115 Intermediate Similarity NPD7697 Approved
0.8115 Intermediate Similarity NPD7696 Phase 3
0.8095 Intermediate Similarity NPD2534 Approved
0.8095 Intermediate Similarity NPD2533 Approved
0.8095 Intermediate Similarity NPD2532 Approved
0.8092 Intermediate Similarity NPD5402 Approved
0.8081 Intermediate Similarity NPD6801 Discontinued
0.8051 Intermediate Similarity NPD7874 Approved
0.8051 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8041 Intermediate Similarity NPD7701 Phase 2
0.8035 Intermediate Similarity NPD1465 Phase 2
0.8035 Intermediate Similarity NPD2801 Approved
0.8011 Intermediate Similarity NPD5494 Approved
0.8011 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7979 Intermediate Similarity NPD7871 Phase 2
0.7979 Intermediate Similarity NPD7870 Phase 2
0.7977 Intermediate Similarity NPD1934 Approved
0.7969 Intermediate Similarity NPD6823 Phase 2
0.7967 Intermediate Similarity NPD7240 Approved
0.7947 Intermediate Similarity NPD7699 Phase 2
0.7947 Intermediate Similarity NPD7700 Phase 2
0.7933 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD7411 Suspended
0.7886 Intermediate Similarity NPD3817 Phase 2
0.7884 Intermediate Similarity NPD6535 Approved
0.7884 Intermediate Similarity NPD6534 Approved
0.7882 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7874 Intermediate Similarity NPD37 Approved
0.7853 Intermediate Similarity NPD6234 Discontinued
0.7845 Intermediate Similarity NPD3751 Discontinued
0.7844 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7841 Intermediate Similarity NPD7768 Phase 2
0.7841 Intermediate Similarity NPD4965 Approved
0.7841 Intermediate Similarity NPD4966 Approved
0.7841 Intermediate Similarity NPD4967 Phase 2
0.7828 Intermediate Similarity NPD7801 Approved
0.7821 Intermediate Similarity NPD3787 Discontinued
0.7795 Intermediate Similarity NPD8320 Phase 1
0.7795 Intermediate Similarity NPD8319 Approved
0.7759 Intermediate Similarity NPD6599 Discontinued
0.7754 Intermediate Similarity NPD8150 Discontinued
0.7701 Intermediate Similarity NPD3226 Approved
0.7697 Intermediate Similarity NPD3749 Approved
0.7688 Intermediate Similarity NPD5403 Approved
0.7679 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD7199 Phase 2
0.7659 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD4628 Phase 3
0.7647 Intermediate Similarity NPD3750 Approved
0.7644 Intermediate Similarity NPD1653 Approved
0.7644 Intermediate Similarity NPD6213 Phase 3
0.7644 Intermediate Similarity NPD6212 Phase 3
0.7644 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD1549 Phase 2
0.7624 Intermediate Similarity NPD5710 Approved
0.7624 Intermediate Similarity NPD5711 Approved
0.7619 Intermediate Similarity NPD2935 Discontinued
0.7616 Intermediate Similarity NPD1511 Approved
0.7616 Intermediate Similarity NPD7390 Discontinued
0.7616 Intermediate Similarity NPD6799 Approved
0.7606 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD7458 Discontinued
0.7581 Intermediate Similarity NPD7685 Pre-registration
0.7574 Intermediate Similarity NPD2346 Discontinued
0.7572 Intermediate Similarity NPD5401 Approved
0.7542 Intermediate Similarity NPD3882 Suspended
0.7538 Intermediate Similarity NPD7584 Approved
0.7529 Intermediate Similarity NPD1512 Approved
0.7515 Intermediate Similarity NPD2796 Approved
0.7486 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD8434 Phase 2
0.7471 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD1510 Phase 2
0.7449 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD7585 Approved
0.7412 Intermediate Similarity NPD1551 Phase 2
0.7386 Intermediate Similarity NPD920 Approved
0.7384 Intermediate Similarity NPD6674 Discontinued
0.7366 Intermediate Similarity NPD7930 Approved
0.7363 Intermediate Similarity NPD7583 Approved
0.7353 Intermediate Similarity NPD3748 Approved
0.7353 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD1607 Approved
0.7337 Intermediate Similarity NPD7229 Phase 3
0.7313 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7311 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7311 Intermediate Similarity NPD8059 Phase 3
0.731 Intermediate Similarity NPD6099 Approved
0.731 Intermediate Similarity NPD6100 Approved
0.7305 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD7680 Approved
0.7288 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD1247 Approved
0.7283 Intermediate Similarity NPD2800 Approved
0.7283 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD1243 Approved
0.7273 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD919 Approved
0.7267 Intermediate Similarity NPD7266 Discontinued
0.7249 Intermediate Similarity NPD5953 Discontinued
0.7234 Intermediate Similarity NPD7286 Phase 2
0.7219 Intermediate Similarity NPD1240 Approved
0.7209 Intermediate Similarity NPD5408 Approved
0.7209 Intermediate Similarity NPD5405 Approved
0.7209 Intermediate Similarity NPD5406 Approved
0.7209 Intermediate Similarity NPD5404 Approved
0.7186 Intermediate Similarity NPD8285 Discontinued
0.7175 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD2799 Discontinued
0.715 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4625 Phase 3
0.7143 Intermediate Similarity NPD7999 Approved
0.7143 Intermediate Similarity NPD7003 Approved
0.713 Intermediate Similarity NPD8067 Phase 3
0.7127 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD2313 Discontinued
0.709 Intermediate Similarity NPD7177 Discontinued
0.7083 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD5124 Phase 1
0.7076 Intermediate Similarity NPD230 Phase 1
0.7071 Intermediate Similarity NPD4363 Phase 3
0.7071 Intermediate Similarity NPD4360 Phase 2
0.7052 Intermediate Similarity NPD7033 Discontinued
0.7039 Intermediate Similarity NPD6273 Approved
0.7035 Intermediate Similarity NPD6651 Approved
0.7021 Intermediate Similarity NPD3926 Phase 2
0.7018 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD4060 Phase 1
0.7018 Intermediate Similarity NPD1613 Approved
0.7011 Intermediate Similarity NPD2438 Suspended
0.701 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6190 Approved
0.7 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.6995 Remote Similarity NPD6844 Discontinued
0.6994 Remote Similarity NPD7097 Phase 1
0.6989 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6832 Phase 2
0.6977 Remote Similarity NPD1933 Approved
0.6919 Remote Similarity NPD4288 Approved
0.6916 Remote Similarity NPD8366 Approved
0.6915 Remote Similarity NPD8127 Discontinued
0.6911 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6901 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6901 Remote Similarity NPD7985 Registered
0.6893 Remote Similarity NPD1652 Phase 2
0.6882 Remote Similarity NPD4908 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data